Usefulness of Aspirin Resistance After Percutaneous Coronary Intervention for Acute Myocardial Infarction in Predicting One-Year Major Adverse Coronary Events
Open Access
- 1 September 2006
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 98 (9), 1156-1159
- https://doi.org/10.1016/j.amjcard.2006.05.041
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Aspirin and clopidogrel resistance: an emerging clinical entityEuropean Heart Journal, 2005
- Relation of Aspirin Resistance to Coronary Flow Reserve in Patients Undergoing Elective Percutaneous Coronary InterventionThe American Journal of Cardiology, 2005
- Enhanced Shear-Induced Platelet Aggregation in Patients Who Experience Subacute Stent Thrombosis: A Case-Control StudyJournal of the American College of Cardiology, 2005
- Stent Thrombosis Is Associated With an Impaired Response to Antiplatelet TherapyJournal of the American College of Cardiology, 2005
- Aspirin resistance: more than just a laboratory curiosityJournal of the American College of Cardiology, 2004
- Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatmentJournal of the American College of Cardiology, 2004
- Aspirin resistance: Table 1BMJ, 2004
- The Importance of von Willebrand Factor Level and Heart Rate Changes in Acute Coronary Syndromes: A Comparison with Chronic Ischemic ConditionsAngiology, 2003
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- EFFECTS OF INTERMITTENT TREATMENT WITH ASPIRIN ON THROMBOXANE AND PROSTACYCLIN FORMATION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1988